LORI HILL: Open Payments
NPI 1477938934 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,989 in 57 payments from 29 companies in 2025. Trend: 2023 $2,916 · 2024 $2,321 · 2025 $2,989
Food & beverage: $2,707Long term medical supply or device loan: $199Education: $83
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $342 |
| GENZYME CORPORATION | 3 | $323 |
| AstraZeneca Pharmaceuticals LP | 3 | $235 |
| Astellas Pharma US Inc | 3 | $152 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $145 |
| EMD Serono, Inc. | 2 | $144 |
| PFIZER INC. | 2 | $140 |
| Gilead Sciences, Inc. | 3 | $136 |
| JAZZ PHARMACEUTICALS INC. | 1 | $133 |
| Novocure Inc. | 1 | $129 |
Products named: KISQALI, SARCLISA, WAYRILZ, REBLOZYL, Vyloy, ICLUSIG, Trodelvy, ZIIHERA.
Industry payments across TN — which companies pay providers there.
